CyberRota Analysis
This is a critical severity vulnerability with a CVSS score of 9.8. See the original NVD description below for full technical details.
CVE
CVE-2022-45611
Severity
CRITICAL
CVSS
9.8
EPSS
0.94%
Original NVD Description
An issue was discovered in Fresenius Kabi PharmaHelp 5.1.759.0 allows attackers to gain escalated privileges via via capture of user login information.
Related CVEs
Other vulnerabilities affecting the same vendor(s)